To include your compound in the COVID-19 Resource Center, submit it here.

Savaysa edoxaban regulatory update

FDA's Cardiovascular and Renal Drugs advisory committee will meet on Oct.

Read the full 116 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE